The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Both companies have been selected for stand-by production by German government
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Subscribe To Our Newsletter & Stay Updated
